Press Releases
-
Certara Appoints Dr. Mark Holbrook to Lead Its Quantitative Systems Toxicology and Safety Division
PRINCETON, NJ, US - Sep 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative systems toxicology and safety (QSTS)
Sep 5, 2018
-
CRF Health Partners Innovative US Biotech with TrialMax® eCOA Solution for Phase III Prostate Oncology Study
PLYMOUTH MEETING, PA - Aug 30, 2018 - CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced that its TrialMax® Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study
Aug 30, 2018
-
Greenphire Named to Inc. 5000 List for Sixth Consecutive Year
KING OF PRUSSIA, PA - Aug 29, 2018 - Greenphire, the global leader in financial software for clinical trials, today announced that it has been named to the 2018 Inc
Aug 29, 2018
-
The Pistoia Alliance Announces Number of Reactions in its Chemical Safety Library Service has Increased Four-Fold
BOSTON, MA - Aug 23, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is today announcing a number of milestones in its Chemical Safety Library (CSL) Service project, launched in March 2017
Aug 22, 2018
-
ERT Appoints Industry Veteran to Advance eCOA Strategy
PHILADELPHIA, PA, UNITED STATES - Aug 20, 2018 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced the appointment of Zaher El-Assi as Executive Vice President and Product Line Executive for electronic Clinical Outcome Assessments (eCOA)
Aug 20, 2018
-
CRF Health Launches Self-Service Model for TrialConsent® Platform
PLYMOUTH MEETING, PA - Aug 20, 2018 - CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industrys first electronic informed consent platform with fully embedded design tool
Aug 20, 2018
-
Certara’s D360 Version 10.5 Extends Platform’s Ability to Optimize Discovery Research Across Therapeutic Modalities
PRINCETON, NJ - Aug 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of D360 v10
Aug 15, 2018
-
ActiveRADAR Expands Leadership Team to Support Industry Demand, Company Momentum
SACRAMENTO, CA, UNITED STATES - Aug 14, 2018 - ActiveRADAR (formerly known as RxTE Health), a company specializing in pharmacy cost reduction programs for employers, today announced the addition of three healthcare executives to its leadership team
Aug 14, 2018
-
TULA Recognized As The 10 Most Trusted Risk and Compliance Solution Providers
NEW JERSEY, NJ - Aug 14, 2018 - Now a days, the risk and compliance solutions are empowering companies to create and coordinate, to control and map solutions to regulatory & internal compliance requirement as well
Aug 14, 2018
-
ALBUMEDIX ANNOUNCES EVALUATION AGREEMENT WITH A TOP PHARMA COLLABORATOR
NNOTTINGHAM, UNITED KINGDOM - Aug 1, 2018 - Nottingham, UK, August 1st – Novartis and Albumedix Ltd. (Albumedix) have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedixs Veltis® technology platform and associated technologies
Aug 1, 2018
-
Certara Experts Highlight Quantitative Systems Pharmacology’s Role in First-in-Human Clinical Trials
PRINCETON, NJ - Jul 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its Letter to the Editor describing the important role that quantitative systems pharmacology (QSP) can play in defining dosing criteria for first-in-human (FIH) clinical trials,1 together with the European Medicines Agencys (EMAs) response
Jul 26, 2018
-
Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”
SOUDERTON, PA - Jul 25, 2018 - Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data through its flagship IXRS® 3 Interactive Response Technology (IRT) debuts a first-in-industry podcast series entitled, Spotlight on IRT: Best Practices
Jul 25, 2018
-
The Pistoia Alliance Launches the 2018 President’s Startup Challenge
- Jul 24, 2018 - The Pistoia Alliance has announced today that entries for its 2018 Presidents Startup Challenge are now open, and will close on Monday, 3rd September 2018
Jul 24, 2018
-
Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket
, PA - Jul 17, 2018 - London, United Kingdom and Wayne, Pennsylvania, USA - Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry
Jul 17, 2018
-
Rho Offers Tips for Cellular Therapy Studies
CHAPEL HILL, NC - Jul 17, 2018 - For Immediate Release Rho Offers Tips for Cellular Therapy StudiesCRO shares challenges for cellular therapy in clinical trials Chapel Hill, NC ̶ July 16, 2018 Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, offers tips on overcoming the challenges associated with cellular therapy clinical trials
Jul 16, 2018
-
MR Solutions installs Hawaii’s first preclinical MRI imaging system
GUILDFORD, UNITED KINGDOM - Jul 16, 2018 - MR Solutions has installed Hawaiis first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research
Jul 16, 2018
-
CluePoints Announces Four Year Partnership with ONO Pharmaceutical and Strengthens RBM Position in Japan
WAYNE, PA - Jul 9, 2018 - CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into a significant enterprise agreement with leading Japanese drug development organization, ONO Pharmaceutical Co
Jul 9, 2018
-
BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio
WESTBURY, NY - Jul 9, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions
Jul 9, 2018
-
KCR expands its service portfolio with Trial Execution Consulting
BOSTON, MA, US - Jul 3, 2018 - KCR, a full-service contract research organization, is extending its service portfolio with Trial Execution Consulting to support clients in translating scientific objectives into operational activity
Jul 3, 2018
-
The Pistoia Alliance Announces First Milestone in Unified Data Model (UDM) Project
- Jul 2, 2018 - Last year, Elsevier, donated its Unified Data Model (UDM) to The Pistoia Alliance. Since the donation, The Pistoia Alliance has been working with the project group – which includes members from BIOVIA, Elsevier, GSK, Novartis and Roche – to develop the model further, with the aim of publishing an open and freely available format for the storage and exchange of drug discovery data
Jul 2, 2018
